SCHEMBL5269766

SCHEMBL5269766

CC(C)Oc1ccc(-c2c(Oc3ccc(C(F)(F)F)cc3)ccc3[nH]c(C(=O)NCC(=O)O)c(Cl)c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.38
EGLN1 Q9GZT9 4/20 0.38
PPARD Q03181 1/20 0.37
ATM Q13315 1/20 0.35
PTPN5 P54829 1/20 0.35
FFAR1 O14842 2/20 0.35
SCN8A Q9UQD0 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
MCL1 Q07820 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266914 0.84 MAPT (0.41) PPARDPTPN5FFAR1
SCHEMBL5268151 0.83 MAPT (0.36) PPARDPTPN5FFAR1SCN8ASCN10A
SCHEMBL5509080 0.79 PTPN5 (0.37) PPARDPTPN5SCN8ASCN10A
SCHEMBL5339900 0.78 BRD4 (0.40)
SCHEMBL5339470 0.77 GPR35 (0.37) PPARDPTPN5SCN8ASCN10AMCL1
SCHEMBL5573980 0.76 MAPT (0.40) PPARDTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5271428 0.76 MAPT (0.41) PPARDPTPN5TUBB4ATUBBTUBA3C
SCHEMBL5269374 0.75 FFAR4 (0.36)
SCHEMBL5267628 0.74 PPARD (0.39) PPARDFFAR1
SCHEMBL5269571 0.74 PTGER4 (0.39) PPARDSCN8ASCN10AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838669-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-10-03 EP disclosed
WO-2006077365-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2006-07-27 WO disclosed